等待開盤 11-06 09:30:00 美东时间
+26.640
+3.51%
Agios Pharmaceuticals announced new data on mitapivat, a pyruvate kinase activator, to be presented at ASH 2025. The data highlights its potential in treating thalassemia, sickle cell disease, and PK deficiency. Key findings include subgroup analysis showing 77.8% of alpha-thalassemia patients achieved transfusion reduction, long-term transfusion-free periods up to 84.3 weeks, and positive results from the ACTIVATE-Kids trial in pediatric PK defi...
11-03 14:01
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.
11-01 01:26
UPDATED 2025 GUIDANCEThe $3.85 midpoint of our annual guidance range for 2025 detailed below is confirmed with a more narrow range expected for earnings per share of $3.80 to $3.90. Our cash flow outlook has increased to
10-30 04:18
(来源:衡水日报) 转自:衡水日报 2025 年,网站建设已然迈入 “技术驱动、体验赋能、战略领航” 的全新时代。如今,企业官网早已突破 “线上名片” 的传统定...
10-29 16:01
(来源:衡水日报) 转自:衡水日报 在数字化竞争白热化的当下,品牌官网早已成为企业链接市场的核心枢纽——既是传递品牌理念、展示产品服务的直观窗口,也是精准获客...
10-29 11:45